Natural History and Clinical Impact of Cryoglobulins in Chronic Hepatitis C: 10-Year Prospective Study of 343 Patients

Gastroenterology

Volumn 133, Issue 3, 2007, Pages 835-842

  Viganò, Mauro ^a   Lampertico, Pietro ^a   Rumi, Maria Grazia ^a   Folli, Christian ^a   Maggioni, Lorena ^b   Morabito, Alberto ^c   Del Ninno, Ersilio ^a   Cicardi, Marco ^b   Colombo, Massimo ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b S Giuseppe Hospital   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CRYOGLOBULIN; INTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL EXAMINATION; COHORT ANALYSIS; CRYOGLOBULINEMIA; DISEASE COURSE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; LABORATORY TEST; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORBIDITY; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SURVIVAL TIME;

EID: 34548527112     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.06.064     Document Type: Article

References (36)

1. Agnello V., Chung R.T., and Kaplan L.M. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327 (1992) 1490-1495
2. Kayali Z., Buckwold V.E., Zimmerman B., et al. Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 36 (2002) 978-985
3. Brouet J.C., Clauvel J.P., Danon F., et al. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 57 (1974) 775-788
4. Agnello V., and De Rosa F. Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol 40 (2004) 341-352
5. Meltzer M., Franklin E.C., Elias K., et al. Cryoglobulinemia-a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 40 (1966) 837-856
6. Silvestri F., Pipan C., Barillari G., et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 87 (1996) 4296-4301
7. Ohsawa M., Shingu N., Miwa H., et al. Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection. Int J Cancer 80 (1999) 237-239
8. Zuckerman E., Zuckerman T., Levine A.M., et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma. Ann Intern Med 127 (1997) 423-428
9. Collier J.D., Zanke B., Moore M., et al. No association between hepatitis C and B-cell lymphoma. Hepatology 29 (1999) 1259-1261
10. Rasul I., Shepherd F.A., Kamel-Reid S., et al. Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology 29 (1999) 543-547
11. Sansonno D., and Dammacco F. Hepatitis C virus, cryoglobulinemia, and vasculitis: immune complex relations. Lancet Infect Dis 5 (2005) 227-236
12. Lunel F., Musset L., Cacoub P., et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106 (1994) 1291-1300
13. Adinolfi L.E., Utili R., Attanasio V., et al. Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinemia in hepatitis C virus patients: a prospective study. Ital J Gastroenterol 28 (1996) 1-9
14. Pawlotsky J.M., Ben Yahia M., Andrè C., et al. Immunulogical disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 19 (1994) 841-848
15. El-Serag H.B., Hampel H., Yeh C., et al. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 36 (2002) 1439-1445
16. Donada C., Crucitti A., Donadon V., et al. Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinemia. J Viral Hepat 5 (1988) 179-185
17. Siagris D., Christofidou M., Tsamandas A., et al. Cryoglobulinemia and progression of fibrosis in chronic HCV infection: cause or effect?. J Infect 49 (2004) 236-241
18. Christensen E. Prognostic models including the Child-Pugh, MELD and Mayo risk scores. Where are we and where should we go?. J Hepatol 41 (2004) 344-350
19. Cicardi M., Cesana B., Del Ninno E., et al. Prevalence and risk factors for the presence of serum cryoglobulins in patients with chronic hepatitis C. J Viral Hep 7 (2000) 138-143
20. Musset L., Diemert M.C., Taibi F., et al. Characterization of cryoglobulins by immunoblotting. Clin Chem 38 (1992) 798-802
21. Cacoub P., Fabiani F.L., Musset L., et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 96 (1994) 124-132
22. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696-699
23. Boccato S., Pistis R., Noventa F., et al. Fibrosis progression in initially mild chronic hepatitis C. J Viral Hepat 13 (2006) 297-302
24. Fraquelli M., Rigamonti C., Casazza G., et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 56 (2007) 968-973
25. Ziol M., Handra-Luca A., Kettaneh A., et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 41 (2005) 48-54
26. EASL International Consensus Conference on Hepatitis C. Paris, 26-28, February 1999, Consensus Statement. European Association for the Study of the Liver. J Hepatol 30 (1999) 956-961
27. Rumi M.G., Del Ninno E., Parravicini M.L., et al. A prospective randomized trial comparing lymphoblastoid to recombinant interferon alfa 2a as therapy for chronic hepatitis C. Hepatology 24 (1996) 1366-1370
28. Bruix J., Sherman M., Llovet J.M., et al., EASL panel of experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 35 (2001) 421-430
29. Alberti A., Noventa F., Benvegnù L., et al. Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infection. Ann Intern Med 137 (2002) 961-964
30. Saadoun D., Asselah T., Resche-Rigon M., et al. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C. Hepatology 43 (2006) 1337-1345
31. Fartoux L., Chazouillières O., Wendum D., et al. Impact of steatosis on progression of fibrosis in patients with mild hepatitis C. Hepatology 41 (2005) 82-87
32. Santagostino E., Colombo M., Cultraro D., et al. High prevalence of serum cryoglobulins in multitransfused hemophilic patients with chronic hepatitis C. Blood 92 (1998) 516-519
33. Roudot-Thoraval F., Bastie A., Pawlotsky J.M., et al. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6.664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus. Hepatology 26 (1997) 485-490
34. Poynard T., Yuen M.F., Ratziu V., et al. Viral hepatitis C. Lancet 362 (2003) 2095-2100
35. Franco V., Tripodo C., Rizzo A., et al. Bone marrow biopsy in Hodgkin's lymphoma. Eur J Haematol 73 (2004) 149-155
36. Gisbert J.P., Garcia-Buey L., Pajares J.M., et al. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 125 (2003) 1723-1732